Hilltop National Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.3M Sell
5,251
-76
-1% -$77.7K 1.34% 15
2026
Q1
$4.9M Buy
5,327
+12
+0.2% +$12.2K 1.17% 17
2025
Q4
$5.71M Sell
5,315
-65
-1% -$62.2K 1.38% 13
2025
Q3
$4.1M Sell
5,380
-332
-6% -$247K 1.01% 19
2025
Q2
$4.45M Buy
+5,712
New +$4.44M 1.16% 16
2024
Q4
$4.14M Sell
5,364
-84
-2% -$69.6K 1.25% 12
2024
Q3
$4.83M Sell
5,448
-42
-0.8% -$37.8K 1.47% 9
2024
Q2
$4.97M Buy
5,490
+75
+1% +$60K 1.6% 7
2024
Q1
$4.21M Buy
+5,415
New +$3.85M 1.43% 9

Other funds holding LLY

Hilltop National Bank's LLY Position: Q2 2026 in Review

Hilltop National Bank reduced its Eli Lilly (LLY) stake by 1.4% in Q2 2026, selling an estimated $77.7K and leaving 5,251 shares worth $6.3M. The position accounts for 1.34% of the portfolio, ranked #15.

Hilltop National Bank first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hilltop National Bank held 5,251 shares of Eli Lilly worth $6.3M as of Q2 2026.
  • Hilltop National Bank sold 76 Eli Lilly shares in Q2 2026, an estimated $77.7K.
  • Eli Lilly made up 1.34% of Hilltop National Bank's portfolio in Q2 2026, its #15 holding.
  • Hilltop National Bank first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.